These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1690083)

  • 1. Cytotoxic mechanisms of murine lymphokine-activated killer cells: functional and biochemical characterization of homogeneous populations of spleen LAK cells.
    Zychlinsky A; Joag S; Liu CC; Young JD
    Cell Immunol; 1990 Apr; 126(2):377-90. PubMed ID: 1690083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.
    Lowrey DM; Hameed A; Lichtenheld M; Podack ER
    Cancer Res; 1988 Aug; 48(16):4681-8. PubMed ID: 3260817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells, cytotoxic T lymphocytes, natural killer receptors and mRNA transcripts for granzymes and perforin.
    Li Q; Liang Z; Nakadai A; Kawada T
    Stress; 2005 Jun; 8(2):107-16. PubMed ID: 16019602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
    Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
    J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization of perforin and serine esterase in lymphokine-activated killer cells and cytotoxic T cells by immunogold labeling.
    Ojcius DM; Zheng LM; Sphicas EC; Zychlinsky A; Young JD
    J Immunol; 1991 Jun; 146(12):4427-32. PubMed ID: 2040805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of target molecule of murine lymphokine-activated killer (LAK) cells and the clones.
    Hashimoto Y; Kato K; Sato N; Yagi H; Yagita H; Nishimura T
    Princess Takamatsu Symp; 1988; 19():315-22. PubMed ID: 3077625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells.
    Ozdemir O; Ravindranath Y; Savaşan S
    J Immunother; 2005; 28(1):44-52. PubMed ID: 15614044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
    Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
    J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 up-regulates perforin- and Fas-mediated lymphokine-activated killer activity by intestinal intraepithelial lymphocytes.
    Ebert EC
    Clin Exp Immunol; 2004 Nov; 138(2):259-65. PubMed ID: 15498035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q; Nakadai A; Takeda K; Kawada T
    Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation by transferrin of IL-2-inducible killer activity and perforin production of human CD8+ T cells.
    Nakamura A; Sone S; Nabioullin R; Sugihara K; Munekata M; Nishioka Y; Nii A; Ogura T
    Clin Exp Immunol; 1993 Apr; 92(1):174-9. PubMed ID: 8467561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
    Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
    J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G; Bochan M; Brahmi Z
    Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of phorbol ester-sensitive protein kinase C isoforms in lymphokine-activated killer cell-mediated cytotoxicity: dissociation between perforin-dependent and Fas-dependent cytotoxicity.
    Ohmi Y; Ohta A; Sasakura Y; Sato N; Yahata T; Santa K; Habu S; Nishimura T
    Biochem Biophys Res Commun; 1997 Jun; 235(3):461-4. PubMed ID: 9207176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.
    Vollenweider I; Moser R; Groscurth P
    Cancer Immunol Immunother; 1994 Nov; 39(5):305-12. PubMed ID: 7987862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells.
    Liu CC; Walsh CM; Eto N; Clark WR; Young JD
    J Immunol; 1995 Jul; 155(2):602-8. PubMed ID: 7608538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and partial characterization of cytoplasmic granules of LAK cells from mice showing side effects of recombinant human IL-2.
    Ueno M; Yahara I; Kishi K
    Fundam Appl Toxicol; 1997 Mar; 36(1):39-46. PubMed ID: 9073465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.